𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interferon therapy in hepatitis C—Refractory hepatitis

✍ Scribed by Uno, Shiro

Book ID
105607288
Publisher
Springer-Verlag
Year
1993
Tongue
English
Weight
430 KB
Volume
28
Category
Article
ISSN
0435-1339

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early changes in interferon signaling de
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients
✍ Birgit Edlich; Golo Ahlenstiel; Aintzane Zabaleta Azpiroz; Jonathan Stoltzfus; M 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 298 KB 👁 1 views

Natural killer (NK) cells exhibit a polarized phenotype with increased cytotoxicity and decreased interferon gamma (IFN-c) production in chronic hepatitis C virus (HCV) infection. Here, we asked whether this is caused by type I interferon (IFN)-induced expression and phosphorylation levels of signal

Therapy of hepatitis C: Consensus interf
Therapy of hepatitis C: Consensus interferon trials
✍ E B Keeffe; F B Hollinger 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 234 KB 👁 2 views

Chronic hepatitis C is an insidious disease associated with prior interferon therapy were more likely to have a serum HCV RNA end-of-retreatment and sustained response than significant morbidity and mortality. Currently, the only approved therapies for chronic hepatitis C are the alpha interfer-pati

Therapy of hepatitis C: Alpha interferon
Therapy of hepatitis C: Alpha interferon and ribavirin
✍ O Reichard; R Schvarcz; O Weiland 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Ribavirin is a nucleoside analogue that has been evaluated as a therapy of chronic hepatitis C alone and in combination with alpha interferon. Ribavirin is well absorbed orally and is typically given in doses of 1,000 to 1,200 mg/d. Three randomized, placebo-controlled studies comprising more than 1